Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | ACTIVE_COMPARATOR | Systane |
| 2 | EXPERIMENTAL | Blink tears |
| Name | Type | Description |
|---|---|---|
| (9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 | DRUG | Drops |
| Systane | DRUG | Drops |
Inclusion Criteria: * Mild to moderate dry eye * over 18 Exclusion Criteria: * No concurrent ocular disease or meds
Blink Tears is an over-the-counter eye drop product with the active ingredient polyethylene glycol 400. It is used for dry eye, and it is developed by Abbott Laboratories, which trades under the ticker ABT. The product is classified as an OTC drug rather than a prescription therapy.
Blink Tears is used for dry eye. It is an over-the-counter product whose active ingredient is polyethylene glycol 400, and it has been studied in mild to moderate dry eye patients. Abbott Laboratories, ticker ABT, is the developer associated with the product.
Blink Tears is made by Abbott Laboratories, which trades on the ticker ABT. Abbott Laboratories is the developer associated with the product, an over-the-counter eye drop whose active ingredient is polyethylene glycol 400 and which is used for dry eye.
Blink Tears has been studied in a Phase 2 clinical trial, and that trial is completed. It is an over-the-counter product with polyethylene glycol 400 as its active ingredient, so it is not described as an investigational prescription drug still moving through clinical development.
Blink Tears has been evaluated in one completed clinical trial, NCT00607776, titled Artificial Tears Study in Mild to Moderate Dry Eye Patients. That Phase 2 study enrolled 110 participants, was randomized, double blind, and used an active control, and it included adults 18 years and older.
Yes, Blink Tears is also known as 9587X. Both names refer to the same over-the-counter product, which contains polyethylene glycol 400 as its active ingredient, is used for dry eye, and is associated with Abbott Laboratories, ticker ABT.